This could be attributed to induced transcription factor NF-E2-related factor 2 (Nrf2), which is activated in prostate cancer independently of ROS [44] and regulates 4-HNE metabolism and activity [45]. The gene discussed is NFE2L2; the disease is prostate carcinoma.